Dysregulation of the Intestinal Microbiome in Patients With Haploinsufficiency of A20.
Lactobacillus salivarius
Streptococcus mutans
haploinsufficiency of A20
inborn errors of immunity
intestinal microbiome
regulatory T cells
Journal
Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359
Informations de publication
Date de publication:
2021
2021
Historique:
received:
01
10
2021
accepted:
28
12
2021
entrez:
14
2
2022
pubmed:
15
2
2022
medline:
6
4
2022
Statut:
epublish
Résumé
Haploinsufficiency of A20 (HA20) is a form of inborn errors of immunity (IEI). IEIs are genetically occurring diseases, some of which cause intestinal dysbiosis. Due to the dysregulation of regulatory T cells (Tregs) observed in patients with HA20, gut dysbiosis was associated with Tregs in intestinal lamina propria. Stool samples were obtained from 16 patients with HA20 and 15 of their family members. Infant samples and/or samples with recent antibiotics use were excluded; hence, 26 samples from 13 patients and 13 family members were analyzed. The 16S sequencing process was conducted to assess the microbial composition of samples. Combined with clinical information, the relationship between the microbiome and the disease activity was statistically analyzed. The composition of gut microbiota in patients with HA20 was disturbed compared with that in healthy family members. Age, disease severity, and use of immunosuppressants corresponded to dysbiosis. However, other explanatory factors, such as abdominal symptoms and probiotic treatment, were not associated. The overall composition at the phylum level was stable, but some genera were significantly increased or decreased. Furthermore, among the seven operational taxonomic units (OTUs) that increased, two OTUs, Detailed interaction on intestinal epithelium remains unknown; the relationship between the disease and stool composition change helps us understand the mechanism of an immunological reaction to microorganisms.
Identifiants
pubmed: 35155270
doi: 10.3389/fcimb.2021.787667
pmc: PMC8834539
doi:
Substances chimiques
RNA, Ribosomal, 16S
0
Tumor Necrosis Factor alpha-Induced Protein 3
EC 3.4.19.12
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
787667Informations de copyright
Copyright © 2022 Toyofuku, Takeshita, Ohnishi, Kiridoshi, Masuoka, Kadowaki, Nishikomori, Nishimura, Kobayashi, Ebato, Shigemura, Inoue, Suda, Hattori, Morio, Honda and Kanegane.
Déclaration de conflit d'intérêts
KH is a scientific advisory board member of Vedanta Biosciences and 4BIO CAPITAL. YK is an employee of JSR Corporation. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Gastroenterology. 2015 Jul;149(1):139-50
pubmed: 25982289
DNA Res. 2013 Jun;20(3):241-53
pubmed: 23571675
Nature. 2012 May 09;486(7402):222-7
pubmed: 22699611
Clin Rev Allergy Immunol. 2019 Oct;57(2):145-165
pubmed: 29754192
Nat Commun. 2021 Feb 18;12(1):1139
pubmed: 33602945
Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18193-8
pubmed: 17991771
J Exp Med. 2010 Oct 25;207(11):2323-30
pubmed: 20921284
Curr Opin Allergy Clin Immunol. 2019 Dec;19(6):563-570
pubmed: 31389816
PLoS One. 2019 Jul 11;14(7):e0218999
pubmed: 31295268
J Clin Immunol. 2021 Nov;41(8):1954-1956
pubmed: 34427832
J Allergy Clin Immunol. 2019 Feb;143(2):775-778.e6
pubmed: 30312711
Scand J Immunol. 2020 Jan;91(1):e12805
pubmed: 31267543
Mucosal Immunol. 2016 Nov;9(6):1455-1465
pubmed: 26982597
Blood. 2016 Oct 20;128(16):2083-2088
pubmed: 27461930
J Allergy Clin Immunol Pract. 2021 Oct;9(10):3767-3780
pubmed: 34246792
Clin Immunol. 2020 Jul;216:108441
pubmed: 32335289
Front Cell Infect Microbiol. 2020 Nov 24;10:572912
pubmed: 33330122
Pediatr Res. 2022 Jan;91(1):35-43
pubmed: 33731809
Microbiome. 2018 Aug 4;6(1):135
pubmed: 30077182
Dig Liver Dis. 2002 Sep;34 Suppl 2:S12-8
pubmed: 12408433
Genome Biol. 2011 Jun 24;12(6):R60
pubmed: 21702898
J Allergy Clin Immunol. 2018 Apr;141(4):1485-1488.e11
pubmed: 29241730
Adv Exp Med Biol. 2021;1278:191-203
pubmed: 33523449
Genome Med. 2018 Sep 28;10(1):70
pubmed: 30261899
Front Immunol. 2021 Aug 02;12:712915
pubmed: 34408753
Appl Environ Microbiol. 2001 Sep;67(9):4374-6
pubmed: 11526051
Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2567-72
pubmed: 15701695